showed that AXL inhibitors impaired ubiquitination and degradation of AXL leading to accumulation of the AXL receptor on the cellular surface, and this might increase tumor proliferation.[60] To address this challenge, Rui et al. This evidence concerns the gene AXL and neoplasm.